𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1009-166 Pulse pressure as cardiovascular risk marker during losartan or atenolol based therapy in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE trial)

✍ Scribed by Eva Gerdts; Vasilios Papademetriou; Kristian Wachtell; Markku Nieminen; Hans Bjornstad; Stanley Franklin; Bjorn Dahlof; Richard B Devereux


Book ID
119549501
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
100 KB
Volume
43
Category
Article
ISSN
1558-3597

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES